Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Dylan M. Glubb
Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated With Sorafenib
Cancer Research
Cancer Research
Oncology
Related publications
Mp78-10 the Influence of Genetic Variants on Clinical Outcomes and Toxic Effects in Patients With Advanced Renal Cell Carcinoma Treated With Sorafenib: A Multi-Center Research
Journal of Urology
Urology
Novel Hematological Biomarkers Predict Survival in Renal Cell Carcinoma Patients Treated With Nephrectomy
Archives of Medical Science
Medicine
Post-Progression Survival and Progression-Free Survival in Patients With Advanced Hepatocellular Carcinoma Treated by Sorafenib
Hepatology Research
Hepatology
Infectious Diseases
Critical Appraisal of Sorafenib in the Treatment of Chinese Patients With Renal Cell Carcinoma
OncoTargets and Therapy
Oncology
Pharmacology
Early Α-Fetoprotein Response Predicts Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib
Journal of Hepatocellular Carcinoma
Impact of Comorbidity on Overall Survival in Patients Surgically Treated for Renal Cell Carcinoma
Urology
Urology
Long Duration of Stable Disease May Improve Overall Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib
Acta Hepatologica Japonica
Hepatology
Gender-Related Differences in Surgically Treated Patients With Renal Cell Carcinoma
Journal of Urological Surgery
Attenuation of Liver Stiffness in Sorafenib-Treated Patients With Advanced Hepatocellular Carcinoma
Hepatoma Research
